Sensyne Health Ltd. engages in the development of clinical artificial intelligence for use in the healthcare and life science sector. It operates through the Healthcare and Life Sciences segments. The Healthcare segment includes software licenses, support and maintenance, and professional services. The Life Sciences segment provides bespoke clinical development services to pharmaceutical and biotechnology customers. The company was founded on June 20, 2018 and is headquartered in Oxford, the United Kingdom.